Cecropin p17

Source / Derivation:

Cecropin p17 is a synthetic peptide based on insect-derived cecropins, developed for preclinical research into antimicrobial and immunomodulatory effects. It is designed to mimic natural insect defense peptides. Cecropin p17 has been studied for its activity against bacterial pathogens and modulation of innate immunity.

Cecropin p17

Mechanism of Action:

Cecropin p17 exerts membrane-disruptive antimicrobial effects and modulates host immune responses. It enhances innate defense mechanisms while promoting microbial clearance. Additionally, Cecropin p17 may help maintain tissue health and reduce infection-related stress in preclinical models.

Clinical Relevance & Potential Outcomes:

Research suggests Cecropin p17 may support enhanced antimicrobial defense and immune modulation. It is explored primarily in preclinical and investigational settings for infectious disease research. Observations indicate potential for studying pathogen resistance and innate immune function.

Intended Clinical Application:

Cecropin p17 is relevant for research and preclinical studies focused on antimicrobial activity and immune system modulation. It is not intended for direct clinical use in humans.

Formulation & Quality Specifications:

Delivered as a liquid prefilled pen
Purity: >98% (HPLC-validated)
Storage: 2–8 °C (refrigerated)
Documentation: Full CoA and MSDS available

Concentration:

Frequency:

Dosage (pen clicks):

Duration:

Notes:

5 mg/ml, total 3 ml, total 15 mg

Daily

1 month

A synthetic antimicrobial peptide that helps fight bacterial infections by disrupting microbial cell membranes.